The quarter's performance marks a continuation of the challenging trends that have plagued ITC over the past year. Sequential analysis reveals that whilst net profit declined 18.45% quarter-on-quarter from ₹5,387.97 crores in Q4 FY26, revenue showed modest sequential growth of 7.24%. This divergence between revenue and profitability trends underscores the margin pressures facing the company across its diversified business portfolio.
The company's stock has been under severe pressure, declining 31.78% over the past year and underperforming the Sensex by 27.97 percentage points. Year-to-date, shares are down 30.29%, reflecting persistent investor concerns about growth visibility and competitive pressures in key segments. The stock currently trades at a price-to-earnings ratio of 16.84x, significantly below the sector average, whilst offering a dividend yield of 5.16%, the highest amongst its FMCG peers.
Financial Performance: Margin Compression Overshadows Revenue Recovery
ITC's Q1 FY27 financial performance presents a mixed picture, with revenue trends showing marginal sequential improvement but year-on-year comparisons revealing significant headwinds. Net sales of ₹19,114.37 crores in Q1 FY27 represent an 11.07% decline from ₹21,494.79 crores in Q1 FY26, though the sequential comparison against Q4 FY26's ₹17,824.68 crores shows a healthier 7.24% growth. This sequential uptick suggests some stabilisation in business activity, though the year-on-year decline raises questions about sustainable growth momentum.
| Metric | Q1 FY27 | Q4 FY26 | Q1 FY26 | QoQ Change | YoY Change |
|---|---|---|---|---|---|
| Net Sales | ₹19,114.37 Cr | ₹17,824.68 Cr | ₹21,494.79 Cr | +7.24% | -11.07% |
| Operating Profit (Excl OI) | ₹5,180.86 Cr | ₹6,924.23 Cr | ₹6,816.47 Cr | -25.18% | -24.00% |
| Operating Margin (Excl OI) | 27.27% | 39.28% | 31.89% | -1201 bps | -462 bps |
| Net Profit (Consolidated) | ₹4,394.13 Cr | ₹5,387.97 Cr | ₹5,244.20 Cr | -18.45% | -16.21% |
| PAT Margin | 23.73% | 31.03% | 25.00% | -730 bps | -127 bps |
The most concerning aspect of the quarter's performance was the severe margin compression. Operating profit excluding other income plummeted 24.00% year-on-year to ₹5,180.86 crores, whilst operating margin contracted sharply to 27.27% from 31.89% in Q1 FY26 and 39.28% in Q4 FY26. This 462 basis points year-on-year margin erosion and a staggering 1,201 basis points sequential decline signal intensifying cost pressures and competitive dynamics across the company's business segments.
Employee costs rose to ₹1,877.01 crores in Q1 FY27, up 12.00% year-on-year, outpacing revenue growth and contributing to margin pressure. The tax rate for the quarter stood at 23.07%, providing some relief compared to the 25.04% rate in Q1 FY26. However, this tax benefit was insufficient to offset the operational headwinds, with profit after tax margin compressing to 23.73% from 25.00% in the year-ago quarter.
Operational Challenges: Return Metrics Under Pressure
Despite the near-term headwinds, ITC continues to demonstrate strong return on capital employed (ROCE) at 50.07% and return on equity (ROE) of 28.83%, both metrics that underscore the company's historically strong capital efficiency. The ROCE of 50.07% is particularly impressive, indicating that for every rupee of capital employed, the company generates over 50 paise in operating profit, a testament to its asset-light business model in key segments like cigarettes and FMCG.
However, the company's balance sheet reveals some concerning trends. Shareholder funds stood at ₹72,507.30 crores as of March 2026, representing a modest increase from ₹70,030.05 crores in the previous year. Current assets grew to ₹50,708.41 crores from ₹43,893.28 crores, whilst current liabilities expanded to ₹16,687.27 crores from ₹14,334.11 crores. This expansion in working capital, coupled with declining profitability, raises questions about cash conversion efficiency.
Key Concern: Deteriorating Financial Trend
ITC's financial trend has been classified as "NEGATIVE" based on Q1 FY27 results. Key negative factors include quarterly PAT declining 22.20% to ₹4,081.88 crores, net sales falling 11.07%, and operating profit to net sales ratio hitting a low of 27.10%. The company's cash and cash equivalents on a half-yearly basis also reached their lowest point at ₹3,008.79 crores, indicating potential liquidity management challenges.
The company maintains a virtually debt-free status with long-term debt of just ₹60 crores as of March 2026, resulting in a negative net debt-to-equity ratio of -0.29, effectively making it a net cash company. This strong balance sheet provides significant financial flexibility for strategic investments and shareholder returns, though the declining cash position warrants monitoring.
Operating cash flow for FY26 reached ₹18,464.31 crores, the highest on record, demonstrating robust cash generation capabilities despite profitability pressures. However, the company deployed ₹16,147 crores in financing activities, primarily towards dividend payments, reflecting its commitment to returning cash to shareholders through its generous dividend policy with a payout ratio of 87.81%.
Industry Context: FMCG Sector Headwinds Intensify
The FMCG sector in India has faced multiple headwinds over the past year, including inflationary pressures on raw materials, subdued rural demand, and intensifying competition from both organised and unorganised players. ITC's diversified portfolio, whilst providing resilience, has also exposed it to challenges across multiple categories. The cigarette business, historically the company's cash cow, continues to face regulatory pressures and taxation headwinds, whilst the FMCG businesses grapple with competitive intensity and distribution challenges.
The company's stock performance relative to the FMCG sector reveals underperformance of 0.29 percentage points over the past year, with ITC declining 31.78% compared to the sector's 31.49% fall. This marginal underperformance suggests sector-wide challenges rather than company-specific issues, though ITC's diversification into hotels and agri-business should theoretically provide better insulation against pure-play FMCG headwinds.
| Quarter | Net Sales (₹ Cr) | Net Profit (₹ Cr) | Operating Margin (%) | PAT Margin (%) |
|---|---|---|---|---|
| Jun'26 | 19,114.37 | 4,394.13 | 27.27% | 23.73% |
| Mar'26 | 17,824.68 | 5,387.97 | 39.28% | 31.03% |
| Dec'25 | 20,047.30 | 4,931.19 | 34.55% | 25.20% |
| Sep'25 | 19,501.63 | 5,126.11 | 34.70% | 26.88% |
| Jun'25 | 21,494.79 | 5,244.20 | 31.89% | 25.00% |
| Mar'25 | 18,765.00 | 19,727.37 | 35.12% | 27.77% |
| Dec'24 | 18,790.17 | 4,934.80 | 34.24% | 25.89% |
Peer Comparison: Valuation Discount Widens
ITC's valuation metrics present an interesting contrast to its FMCG peers, trading at a significant discount on most parameters whilst offering superior dividend yields. At a price-to-earnings ratio of 16.84x, ITC trades at a steep discount to Hindustan Unilever's 41.48x, Nestle India's 78.22x, Britannia Industries' 51.46x, and even Tata Consumer's 64.98x. This valuation gap reflects market concerns about growth sustainability and the challenges inherent in ITC's cigarette-heavy business model.
| Company | P/E (TTM) | P/BV | ROE (%) | Div Yield (%) | Debt/Equity |
|---|---|---|---|---|---|
| ITC | 16.84 | 4.85 | 28.29 | 5.16 | -0.29 |
| Hind. Unilever | 41.48 | 10.13 | 20.82 | 1.95 | -0.12 |
| Nestle India | 78.22 | 56.21 | 65.72 | 0.93 | -0.17 |
| Britannia Inds. | 51.46 | 25.53 | 54.22 | 3.06 | -0.12 |
| Godrej Consumer | 53.84 | 8.63 | 14.97 | 1.88 | 0.12 |
| Tata Consumer | 64.98 | 4.92 | 7.08 | 0.92 | -0.07 |
On return metrics, ITC's ROE of 28.29% positions it favourably against peers like Hindustan Unilever (20.82%), Godrej Consumer (14.97%), and Tata Consumer (7.08%), though it lags Nestle India (65.72%) and Britannia (54.22%). Higher ROE indicates better capital efficiency and profitability—ITC's 28.29% ROE demonstrates that the company generates strong returns on shareholder equity, a key strength that supports its investment case despite near-term headwinds.
The price-to-book ratio of 4.85x also trades at a significant discount to most peers, with only Tata Consumer (4.92x) trading at similar levels. This suggests the market is pricing in limited growth expectations for ITC relative to pure-play FMCG companies, despite its superior dividend yield of 5.16%, which far exceeds the peer group average of approximately 2.00%.
Valuation Analysis: Discount Reflects Growth Concerns
ITC's current valuation of 16.84x trailing twelve-month earnings represents a considerable discount to both its historical averages and sector peers. The company's enterprise value-to-EBITDA multiple of 12.10x and EV/EBIT of 12.91x are relatively modest for a company of ITC's quality and market position, suggesting the market is factoring in structural headwinds to the cigarette business and execution challenges in scaling its FMCG portfolio.
The dividend yield of 5.16% stands as a key attraction for income-seeking investors, particularly in the current market environment. The company's latest dividend of ₹8 per share, coupled with a payout ratio of 87.81%, demonstrates management's commitment to returning cash to shareholders. However, this high payout ratio also raises questions about capital allocation priorities and whether the company is retaining sufficient capital for growth investments in its FMCG and hotels businesses.
The valuation grade has recently improved from "Very Expensive" to "Expensive", reflecting the stock's decline from its 52-week high of ₹426.50 to the current level of ₹280.95, a fall of 34.13%. At current levels, the stock trades just 2.16% above its 52-week low of ₹275.00, suggesting limited downside risk from a technical perspective, though fundamental concerns persist.
Shareholding Pattern: Institutional Exodus Continues
The shareholding pattern reveals concerning trends in institutional investor confidence. Foreign Institutional Investors (FIIs) have been consistent sellers, reducing their stake from 37.98% in June 2025 to 34.23% in June 2026, a cumulative reduction of 375 basis points over five quarters. This sustained selling pressure from FIIs, who typically take long-term positions, signals concerns about the company's growth trajectory and regulatory risks in the cigarette business.
| Shareholder Category | Jun'26 | Mar'26 | Dec'25 | Sep'25 | QoQ Change |
|---|---|---|---|---|---|
| FII Holding | 34.23% | 34.83% | 36.11% | 37.39% | -0.60% |
| Mutual Fund Holding | 16.50% | 16.76% | 16.17% | 14.30% | -0.26% |
| Insurance Holdings | 20.83% | 20.36% | 20.20% | 20.40% | +0.47% |
| Other DII Holdings | 11.85% | 12.06% | 12.56% | 12.74% | -0.21% |
| Non-Institutional | 16.60% | 15.98% | 14.96% | 15.17% | +0.62% |
Mutual funds have also marginally reduced their holdings from 16.76% to 16.50% in Q1 FY27, though their stake has increased from 13.76% in June 2025, suggesting some accumulation during the stock's decline. Insurance companies increased their stake to 20.83% from 20.36%, providing some support. The rise in non-institutional holdings from 15.98% to 16.60% quarter-on-quarter indicates retail investor interest, possibly attracted by the high dividend yield and depressed valuations.
Overall institutional holdings stand at 83.40%, dominated by 669 FIIs and 49 mutual funds, indicating broad-based institutional participation despite the recent selling. The absence of promoter holding, as ITC is professionally managed without a controlling shareholder, means institutional investor sentiment plays a crucial role in stock price movements.
Stock Performance: Severe Underperformance Across Timeframes
ITC's stock performance has been disappointing across virtually all timeframes, with the stock generating negative alpha against the Sensex benchmark. Over the past year, ITC has declined 31.78% compared to the Sensex's 3.81% fall, resulting in a negative alpha of 27.97 percentage points. This severe underperformance reflects sustained selling pressure and deteriorating investor sentiment towards the stock.
| Period | ITC Return | Sensex Return | Alpha |
|---|---|---|---|
| 1 Week | -0.93% | +2.68% | -3.61% |
| 1 Month | -3.22% | +1.52% | -4.74% |
| 3 Months | -10.80% | +1.54% | -12.34% |
| 6 Months | -12.80% | -5.07% | -7.73% |
| YTD | -30.29% | -8.36% | -21.93% |
| 1 Year | -31.78% | -3.81% | -27.97% |
| 2 Years | -40.00% | -4.46% | -35.54% |
| 3 Years | -36.21% | +17.39% | -53.60% |
The three-year performance is particularly concerning, with ITC declining 36.21% whilst the Sensex gained 17.39%, resulting in a massive negative alpha of 53.60 percentage points. This sustained underperformance across multiple timeframes suggests structural challenges rather than temporary headwinds. The stock's beta of 0.61 indicates it is less volatile than the broader market, classified as a "Low Beta Stock", though this has not prevented significant capital erosion.
From a risk-adjusted perspective, ITC's one-year return of -31.78% with volatility of 19.90% results in a negative risk-adjusted return of -1.60, compared to the Sensex's -0.28. The stock currently trades below all major moving averages—5-day (₹284.55), 20-day (₹282.29), 50-day (₹286.33), 100-day (₹295.11), and 200-day (₹333.34)—indicating persistent bearish momentum across all timeframes.
Investment Thesis: Quality Company Facing Cyclical Headwinds
ITC's investment thesis rests on its classification as an "Excellent" quality company with strong fundamentals, offset by near-term operational challenges and negative momentum. The company's quality assessment, maintained at "Excellent" since May 2026, reflects its strong financial performance over the long term, characterised by consistent profitability, robust return metrics, zero debt, and generous dividend payouts.
Key quality indicators include a five-year sales CAGR of 9.55%, EBIT growth of 10.77%, average ROCE of 45.54%, and average ROE of 28.29%. The company maintains a net cash position with a debt-to-equity ratio of -0.29, interest coverage exceeding 100 times, and zero promoter pledging. Institutional holdings of 83.40% reflect continued confidence from sophisticated investors despite recent selling pressure.
However, the investment case is challenged by a "Negative" financial trend and "Mildly Bearish" technical indicators. The proprietary Mojo score of 45/100 places ITC in the "SELL" category, with the recommendation to "Consider selling" and "Look for exit opportunities". This rating reflects the confluence of deteriorating quarterly financials, persistent underperformance against benchmarks, and weak technical momentum.
Key Strengths & Risk Factors
✓ KEY STRENGTHS
- Exceptional Dividend Yield: 5.16% yield, highest amongst FMCG peers, provides strong income cushion for investors
- Debt-Free Balance Sheet: Net cash company with debt-to-equity of -0.29 provides significant financial flexibility
- Strong Return Metrics: ROCE of 50.07% and ROE of 28.83% demonstrate superior capital efficiency
- Diversified Business Model: Presence across cigarettes, FMCG, hotels, and agri-business provides revenue stability
- Robust Cash Generation: Operating cash flow of ₹18,464 crores (FY26) demonstrates strong cash conversion
- High Institutional Participation: 83.40% institutional holdings indicate sophisticated investor base
- Market Leadership: Dominant positions in cigarettes and growing presence in FMCG categories
⚠ KEY CONCERNS
- Severe Revenue Decline: 11.07% YoY fall in Q1 FY27 sales raises questions about growth sustainability
- Margin Compression: Operating margin fell 462 bps YoY to 27.27%, indicating cost and competitive pressures
- Persistent Underperformance: 27.97% negative alpha vs Sensex over one year reflects weak investor sentiment
- Institutional Selling: FII stake declined 375 bps over five quarters, signalling confidence erosion
- Negative Financial Trend: Quarterly PAT, sales, and margins all at multi-quarter lows
- Regulatory Risks: Cigarette business faces ongoing taxation and regulatory headwinds
- FMCG Execution Challenges: Scaling non-cigarette businesses remains a work in progress
Outlook: What to Watch
POSITIVE CATALYSTS
- Stabilisation of operating margins above 30% in coming quarters
- Sequential revenue growth acceleration beyond Q1's 7.24% QoQ improvement
- Reversal of FII selling trend with stake stabilisation or increase
- Significant market share gains in FMCG categories to offset cigarette headwinds
- Technical breakout above 200-day moving average of ₹333.34
RED FLAGS
- Further margin compression below 25% operating margin levels
- Continued YoY revenue declines in Q2 FY27 and beyond
- Acceleration of institutional selling, particularly from insurance companies
- Reduction in dividend payout ratio from current 87.81% levels
- Technical breakdown below 52-week low of ₹275.00
The path forward for ITC depends critically on management's ability to arrest the margin decline and reignite revenue growth across its diversified portfolio. The company's strong balance sheet and cash generation provide a cushion to weather near-term headwinds, whilst the high dividend yield offers downside protection. However, sustained improvement in quarterly financials and a reversal of the negative trend will be essential to restore investor confidence and justify a re-rating from current depressed valuations.
The Verdict: Quality Company in Temporary Distress
Score: 45/100
For Fresh Investors: Avoid initiating positions at current levels despite attractive dividend yield. Wait for clear signs of margin stabilisation and revenue growth recovery before considering entry. The negative financial trend and persistent institutional selling suggest further downside risk.
For Existing Holders: Consider reducing positions on any technical bounce towards the ₹295-300 range (100-day moving average). The high dividend yield of 5.16% provides some holding rationale for long-term income investors, but capital appreciation prospects appear limited in the near term. Maintain strict stop-loss discipline.
Fair Value Estimate: ₹265-275 (5.35% downside to 2.16% upside from current ₹280.95)
ITC's Q1 FY27 results underscore the challenges facing this diversified conglomerate as it navigates regulatory pressures in cigarettes, competitive intensity in FMCG, and execution challenges in scaling its non-cigarette businesses. Whilst the company's excellent quality credentials, debt-free balance sheet, and generous dividend yield provide a safety net, the deteriorating financial trend, margin compression, and sustained underperformance warrant a cautious stance. Only a decisive turnaround in quarterly metrics and reversal of institutional selling would justify upgrading the investment outlook.
Note- ROCE= (EBIT - Other income)/(Capital Employed - Cash - Current Investments)
⚠️ Investment Disclaimer
This article is for educational and informational purposes only and should not be construed as financial advice. Investors should conduct their own due diligence, consider their risk tolerance and investment objectives, and consult with a qualified financial advisor before making any investment decisions.
